Rejected at 2:10 a.m. Nov, 01, 2023 ] by Ahmed7
Author: Carrotid
Related Note: 1488765280375 1
Rationale for change

Factor VII has shorter half-life than those of protein C & S https://www.researchgate.net/figure/Plasma-Levels-Half-lives-and-Availability-of-Concentrates-for-Coagulation-Factors-and_tbl1_46820825

Rejection reason

please resubmit with an acceptable source

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::02_Warfarin #AK_Step2_v12::#UWorld::Step::4736 #AK_Step2_v12::#FirstAid::07_Hematology::01_Coagulation_Disorders::01_Normal_Hemostasis #AK_Step2_v12::#AMBOSS::9x0NAR #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::01_Warfarin #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#AMBOSS::Xz09ri #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step2_v12::#UWorld::COMLEX::101516 #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#AMBOSS::tQaXB4 #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::07_Anticoagulant_Drugs #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::10_Anticoagulation #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::03_Hypercoagulable_States #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::01_Bleeding_&_Clotting_Disorders::01_Bleeding_Disorders:_Coagulation_Factor_Disorders_DDx #AK_Step2_v12::#AMBOSS::wx0hAR #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::03_Warfarin #AK_Step1_v12::#AMBOSS::M5aMkO #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::03_Hypercoagulable_States #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::02_Warfarin #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::HemeOnc #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::09_Vitamin_K_Dependent_Coagulation_Factors #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_zanki #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::02_Coagulation::05_Anticoagulants